Document details

Cyclooxygenase-2 immunoexpression in breast cancer : progesterone receptor influence

Author(s): Almeida, Micaela Carina Pereira

Date: 2010

Persistent ID: http://hdl.handle.net/10400.6/2311

Origin: uBibliorum

Subject(s): Cancro da mama; Cancro da mama - Ciclooxigenase 2; Cancro da mama - Receptor de progesterona; Cancro da mama - Receptor de estrogénio


Description

In breast cancer cyclooxygenase-2 expression is related with high local estrogen receptor levels and consequent poor outcomes, but the clinical relevance of cyclooxygenase-2 is still unclear. We analyzed, by immunostaining, cyclooxygenase-2 and progesterone receptor expression in 31 cases of women with invasive ductal carcinoma, from Child and Women department of Cova da Beira Medical Center. Cyclooxygenase-2 and progesterone receptor expression was observed in 64.5% and 54.8% of the tumors, respectively. We verified that tumors with progesterone receptor expression had lower size and the majority of women with these tumors had no axillary node metastasis, when compared to tumors with positive progesterone receptor. Similar results were found when a correlation between progesterone receptor, cyclooxygenase-2 and clinicopathological factors was performed. These results suggest that progesterone receptor has a protective role in breast cancer by inflammatory pathway modulation. COX-2+/PR+ seems to be a marker of better behavior in ductal invasive breast cancer. We speculate if cyclooxygenase-2 determination may have be a clinical usefulness in clinical practice. It’s expected that further studies may clarify this issue.

Document Type Master thesis
Language English
Advisor(s) Moutinho, José Alberto Fonseca; Muñoz Moreno, Javier
Contributor(s) Almeida, Micaela Carina Pereira
facebook logo  linkedin logo  twitter logo 
mendeley logo

Related documents

No related documents